BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15682639)

  • 1. Highly specific and sensitive, immunoblot-detected 54 kDa antigen from Fonsecaea pedrosoi.
    Vidal MS; Castro LG; Cavalcante SC; Lacaz CS
    Med Mycol; 2004 Dec; 42(6):511-5. PubMed ID: 15682639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis.
    Vidal MS; de Castro LG; Cavalecate SC; Lacaz Cda S
    Rev Inst Med Trop Sao Paulo; 2003; 45(6):315-8. PubMed ID: 14762630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early immune response against Fonsecaea pedrosoi requires Dectin-2-mediated Th17 activity, whereas Th1 response, aided by Treg cells, is crucial for fungal clearance in later stage of experimental chromoblastomycosis.
    Siqueira IM; Wüthrich M; Li M; Wang H; Las-Casas LO; de Castro RJA; Klein B; Bocca AL
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008386. PubMed ID: 32542003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-type hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media.
    Corbellini VA; Scroferneker ML; Carissimi M; Santolin LD
    Mycopathologia; 2006 Jul; 162(1):51-5. PubMed ID: 16830192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of delayed hypersensitivity to Fonsecaea pedrosoi metabolic antigen (chromomycin).
    Garcia Marques S; Pedroso E Silva Cde M; Aparecida Resende M; Moura Silva AA; Mendes Caldas Ade J; Lopes Costa JM
    Nihon Ishinkin Gakkai Zasshi; 2008; 49(2):95-101. PubMed ID: 18451590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes.
    Alviano DS; Franzen AJ; Travassos LR; Holandino C; Rozental S; Ejzemberg R; Alviano CS; Rodrigues ML
    Infect Immun; 2004 Jan; 72(1):229-37. PubMed ID: 14688100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen distribution and antigen-presenting cells in skin biopsies of human chromoblastomycosis.
    Sotto MN; De Brito T; Silva AM; Vidal M; Castro LG
    J Cutan Pathol; 2004 Jan; 31(1):14-8. PubMed ID: 14675280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.
    Azevedo CD; Bruña-Romero O; Marques SG; Nascimento FR; Pinto MC; Silva LA; Bouillet LE; Azevedo FS; Stoianoff MA
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1791-7. PubMed ID: 24832023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei.
    Iwatsu T; Miyaji M; Taguchi H; Okamoto S
    Mycopathologia; 1982 Jan; 77(1):59-64. PubMed ID: 7070478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-γ production.
    Dong B; Tong Z; Li R; Chen SC; Liu W; Liu W; Chen Y; Zhang X; Duan Y; Li D; Chen L
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006237. PubMed ID: 29481557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod.
    Belda W; Criado PR; Passero LFD
    J Dermatol; 2020 Apr; 47(4):409-412. PubMed ID: 31960479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis.
    de Andrade TS; Cury AE; de Castro LG; Hirata MH; Hirata RD
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):267-72. PubMed ID: 17338941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides.
    Nimrichter L; Cerqueira MD; Leitão EA; Miranda K; Nakayasu ES; Almeida SR; Almeida IC; Alviano CS; Barreto-Bergter E; Rodrigues ML
    Infect Immun; 2005 Dec; 73(12):7860-8. PubMed ID: 16299276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin test-active substance prepared from culture filtrate of Fonsecaea pedrosoi.
    Iwatsu T; Miyaji M; Taguchi H; Okamoto S; Kurita N
    Mycopathologia; 1979 May; 67(2):101-5. PubMed ID: 573371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle.
    Khan S; Kumar A; Vinod V; Prabhakar V; Eapen M; Thomas J; Dinesh K; Karim S
    J Infect Dev Ctries; 2015 Mar; 9(3):325-9. PubMed ID: 25771474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
    Fransisca C; He Y; Chen Z; Liu H; Xi L
    Med Mycol; 2017 Nov; 55(8):851-858. PubMed ID: 28053146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytosis of Fonsecaea pedrosoi conidia, but not sclerotic cells caused by Langerhans cells, inhibits CD40 and B7-2 expression.
    da Silva JP; da Silva MB; Salgado UI; Diniz JA; Rozental S; Salgado CG
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):104-11. PubMed ID: 17451443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages.
    Nimrichter L; Barreto-Bergter E; Mendonça-Filho RR; Kneipp LF; Mazzi MT; Salve P; Farias SE; Wait R; Alviano CS; Rodrigues ML
    Microbes Infect; 2004 Jun; 6(7):657-65. PubMed ID: 15158773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.